Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Cytokine & Growth Factor Reviews|May 2, 2021
Principles of the activin receptor signaling pathway and its inhibitionAndreas LodbergMethodsx|October 21, 2020
Rodent model of disuse-induced bone loss by hind limb injection with botulinum toxin AMikkel Bo Brent, Andreas Lodberg, Jesper Skovhus Thomsen, et al.Analytical Chemistry|January 26, 2024
Highly Responsive Bioassay for Quantification of GlucocorticoidsMathias Flensted Poulsen, Martin Overgaard, Christian Brix Folsted Andersen, et al.Bone Reports|April 6, 2017
Immobilization induced osteopenia is strain specific in miceAndreas Lodberg, Jens Bay Vegger, Michael Vinkel Jensen, et al.Bone|March 3, 2018
A soluble activin type IIA receptor mitigates the loss of femoral neck bone strength and cancellous bone mass in a mouse model of disuse osteopeniaAndreas Lodberg, Marco Eijken, Bram C J van der Eerden, et al.Bone Reports|October 6, 2025
High-fat diet induced obesity and anti-activin receptor antibody: Effects on bone properties in miceFrederik Duch Bromer, Andreas Lodberg, Lykke Sylow, et al.Frontiers in Endocrinology|November 16, 2020
Sex-Specific Effect of High-Fat Diet on Glycerol Metabolism in Murine Adipose Tissue and LiverFrancesco Maria Iena, Johanne Blanner Jul, Jens Bay Vegger, et al.Journal of Cachexia, Sarcopenia and Muscle|January 31, 2025
The Effect of Anti-Activin Receptor Type IIA and Type IIB Antibody on Muscle, Bone and Blood in Healthy and Osteosarcopenic MiceFrederik Duch Bromer, Andreas Lodberg, Marco Eijken, et al.Cancer Medicine|November 12, 2020
Inhibition of the activin receptor signaling pathway: A novel intervention against osteosarcomaDaniela Meier, Andreas Lodberg, Ana Gvozdenovic, et al.Bone|October 18, 2020
Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic miceMikkel Bo Brent, Andreas Lodberg, Frederik Duch Bromer, et al.Pageof 2